To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
61 Current news of Sartoriusrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Sartorius started off fiscal 2019 with substantial double-digit growth in order intake, sales revenue and earnings. Consolidated first-quarter sales revenue rose in constant currencies by 16.8% to 435.7 million reported: 19.4%); order intake increased 16.6% to 482.8 million euros (reported: ...
Bioprocess Solutions and the Americas especially strong
Sartorius continued on the growth track in 2018 in both divisions and across all geographies, and thus achieved its forecast raised considerably at mid-year. According to preliminary figures, Group sales revenue rose in constant currencies by 13.2% to 1,566.0 million euros (reported: 11.5%). The ...
The Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the company’s Executive ...
Growth dynamics of the Lab Products & Services Division impacted by softer European demand
Sartorius continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kreuzburg, Chief Executive Officer. “This applies particularly to the Bioprocess Solutions Division, ...
Exchange rate effects dampen profit growth
Sartorius looks back on a successful first quarter 2018. "Both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. On the currency side, however, we faced some headwinds, especially due to the ...
Sales to rise through organic growth and acquisitions
Sartorius intends to continue on its profitable growth track over the long term. According to its new medium-term targets that presented at the company’s annual press conference and its Capital Markets Day, the Group expects to achieve sales of around 4 billion euros in 2025. Management’s plan is ...
Positive effects expected from U.S. tax reform
Sartorius grew substantially according to its preliminary figures for fiscal 2017, with sales revenue up 9.3% to 1,404.6 million euros, and increased its underlying earnings to 353.2 million euros. "In 2017, Sartorius continued on its profitable growth track, executed two strategically important ...
The Lab Products & Services Division records significant double-digit growth due to organic growth and acquisitions
Sartorius recorded further growth in the first nine months of 2017 despite a partly challenging business environment. "This year, different influences shaped the business development of our divisions," commented Group CEO Dr. Joachim Kreuzburg on the results. "While our Lab Products & Services ...
The largest single investment of Sartorius Campus totaling around 42 million euros
With its new facility for the manufacture of laboratory instruments, Sartorius provides high-quality production conditions and an advanced, efficient work environment. The biopharmaceutical and laboratory equipment supplier officially opened its approximately 42-million-euro new building as part ...
Sartorius increased its sales revenue and earnings in the first quarter of 2017 by double digits. "Both divisions successfully started off the current year. Lab Products & Services achieved considerable organic growth, and with the acquisition of Essen BioScience, it added another innovative ...